Kfir Feffer, Hyewon Helen Lee, Wei Wu, Amit Etkin, Ilya Demchenko, Terri Cairo, Frank Mazza, Peter Fettes, Farrokh Mansouri, Kamaldeep Bhui, Zafiris J Daskalakis, Daniel M Blumberger, Peter Giacobbe, Jonathan Downar
BACKGROUND: Recently, a small literature has emerged suggesting that repetitive transcranial magnetic stimulation (rTMS) may offer benefit for MDD even in BPD patients, perhaps by enhancing cognitive control, and/or disrupting excessive 'non-reward' activity in right orbitofrontal regions. This study aimed primarily to assess the therapeutic effects of dorsomedial prefrontal cortex (DMPFC)-rTMS against MDD symptoms in BPD patients, and secondarily to assess whether the therapeutic effects ensued via mechanisms of reduced impulsivity and core BPD pathology on clinical scales (BIS-11, ZAN-BPD) or of reduced alpha- and theta-band activity on EEG recordings of right orbitofrontal cortex...
December 20, 2021: Journal of Affective Disorders